Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. A. Nimirskaya"'
Publikováno v:
Антибиотики и Химиотерапия, Vol 64, Iss 1-2, Pp 9-13 (2020)
The experiment on guinea pigs shows that Ingavirin, when administered orally in a single dose of 15 mg/kg on the 4 th day after vaccination with TEOVac, reduces accumulation of vaccine virus in organs and tissues of animals without affecting the immu
Externí odkaz:
https://doaj.org/article/c3dae5d1df2b4fbc94a3498c03de9f5a
Autor:
S. A. Melnikov, I. V. Borisevich, E. V. Rozhdestvensky, V. B. Pantyukhov, N. K. Chernikova, E. V. Gordeev, S. A. Nimirskaya, A. L. Khmelev, S. I. Syromyatnikova, I. V. Shatokhina, T. M. Plekhanova, G. D. Timankova, S. V. Borisevich, D. A. Kutaev, L. F. Stovba, E. Yu. Mishalova
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 20, Iss 1, Pp 50-59 (2020)
Ebola outbreak in eastern parts of the Democratic Republic of the Congo in 2018–2020 proved that the virus remains highly hazardous for humans, and the outbreak in West Africa in 2014–2016, which was the largest Ebola outbreak in history, showed
Externí odkaz:
https://doaj.org/article/f5fc0ee6d408482f8c589e340d27bfb5
Autor:
Е. Yu. Mishalova, E. V. Gordeev, V. N. Lebedev, S. A. Melnikov, S. A. Nimirskaya, S. V. Borisevich
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 19, Iss 4, Pp 261-267 (2019)
Haemorrhagic fever caused by the Ebola virus is a highly hazardous infectious disease with a mortality rate of 50– 90 %. Heterologous immunoglobulins with a high virus-neutralizing titer are an important element of the WHO-endorsed set of measures
Externí odkaz:
https://doaj.org/article/1676b869846b4088ac3ca3ab5a0dbc96
Autor:
V. N. Podkuyko, A. K. Yakovlev, V. P. Krasnyansky, S. V. Borisevich, N. K. Chernikova, E. A. Yakovlev, A. P. Pirozhkov, D. N. Lega, S. V. Nazarov, E. V. Gordeev, Ya. V. Polyansky, E. V. Rozhdestvensky, S. A. Nimirskaya
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 17, Iss 3, Pp 187-192 (2018)
Analysis of methodological approaches to preclinical evaluation of sensitizing activity of horse serum products shows that the anaphylactogenicity scale recommended in national regulatory documents is imperfect as it is not capable of fully predictin
Externí odkaz:
https://doaj.org/article/2ec103d788ba48b582d3cae5d0b62503